SCL Science Inc. (KOSDAQ:246960)

SCL Science Statistics

Total Valuation

SCL Science has a market cap or net worth of KRW 74.67 billion. The enterprise value is 99.84 billion.

Market Cap	74.67B
Enterprise Value	99.84B

Important Dates

The last earnings date was Friday, April 3, 2026.

Earnings Date	Apr 3, 2026
Ex-Dividend Date	n/a

Share Statistics

SCL Science has 34.02 million shares outstanding. The number of shares has increased by 12.50% in one year.

Current Share Class	34.02M
Shares Outstanding	34.02M
Shares Change (YoY)	+12.50%
Shares Change (QoQ)	+1,158.42%
Owned by Insiders (%)	1.65%
Owned by Institutions (%)	n/a
Float	15.48M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.39
PB Ratio	2.76
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-25.38
EV / Sales	4.54
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-52.33

Financial Position

The company has a current ratio of 1.12, with a Debt / Equity ratio of 1.06.

Current Ratio	1.12
Quick Ratio	0.93
Debt / Equity	1.06
Debt / EBITDA	n/a
Debt / FCF	-15.07
Interest Coverage	-1.60

Financial Efficiency

Return on equity (ROE) is -19.30% and return on invested capital (ROIC) is -5.61%.

Return on Equity (ROE)	-19.30%
Return on Assets (ROA)	-4.08%
Return on Invested Capital (ROIC)	-5.61%
Return on Capital Employed (ROCE)	-5.78%
Weighted Average Cost of Capital (WACC)	6.89%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.42
Inventory Turnover	17.86

Taxes

Income Tax	-651.31M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +7.34% in the last 52 weeks. The beta is 0.55, so SCL Science's price volatility has been lower than the market average.

Beta (5Y)	0.55
52-Week Price Change	+7.34%
50-Day Moving Average	2,109.38
200-Day Moving Average	2,446.85
Relative Strength Index (RSI)	51.88
Average Volume (20 Days)	126,263

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SCL Science had revenue of KRW 22.01 billion and -3.93 billion in losses. Loss per share was -120.00.

Revenue	22.01B
Gross Profit	4.20B
Operating Income	-3.40B
Pretax Income	-4.77B
Net Income	-3.93B
EBITDA	-352.77M
EBIT	-3.40B
Loss Per Share	-120.00

Balance Sheet

The company has 6.22 billion in cash and 28.76 billion in debt, with a net cash position of -22.53 billion or -662.40 per share.

Cash & Cash Equivalents	6.22B
Total Debt	28.76B
Net Cash	-22.53B
Net Cash Per Share	-662.40
Equity (Book Value)	27.09B
Book Value Per Share	228.77
Working Capital	2.47B

Cash Flow

In the last 12 months, operating cash flow was -1.03 billion and capital expenditures -878.74 million, giving a free cash flow of -1.91 billion.

Operating Cash Flow	-1.03B
Capital Expenditures	-878.74M
Depreciation & Amortization	3.05B
Net Borrowing	12.47B
Free Cash Flow	-1.91B
FCF Per Share	-56.09

Margins

Gross margin is 19.09%, with operating and profit margins of -15.44% and -17.87%.

Gross Margin	19.09%
Operating Margin	-15.44%
Pretax Margin	-21.68%
Profit Margin	-17.87%
EBITDA Margin	-1.60%
EBIT Margin	-15.44%
FCF Margin	n/a

Dividends & Yields

SCL Science does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.50%
Shareholder Yield	-12.50%
Earnings Yield	-5.27%
FCF Yield	-2.56%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 30, 2025. It was a forward split with a ratio of 4.

Last Split Date	Jun 30, 2025
Split Type	Forward
Split Ratio	4

Scores

SCL Science has an Altman Z-Score of 0.32 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.32
Piotroski F-Score	2